Richard Cappetta, President and CEO of MicroVention, Inc., said: "The HEAT trial is intended to provide evidence that our second-generation hydrogel coil technologies provide superior long-term ...

HOUSTON -- Treating medium-sized intracranial aneurysms with second-generation hydrogel coils diminished adverse outcomes compared with standard platinum coils, researchers reported here. Physicians ...

Please provide your email address to receive an email when new articles are posted on . Patients with intracranial aneurysms who underwent embolization with second-generation hydrogel-coated coils ...

MIAMI & ALISO VIEJO, Calif.--(BUSINESS WIRE)-- MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced that the SOFIA™ EX 5F 115 cm Intracranial ...

US-based neuroendovascular device company MicroVention has announced a court settlement against three former members of staff accused of misappropriating trade secrets about the company’s embolic ...

DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j87v3m/global) has announced the addition of the "Global ...

Research and Markets has announced the addition of the "Global Neuroendovascular Coil and Non-Coil Devices Market - Growth, Trends and Forecasts (2016 - 2021)" report to their offering. The research ...

MicroVention Inc., OC’s sixth-largest device maker by local employee count with 1,200 area workers, named Carsten Schroeder chief executive and president, beginning early November. Schroeder comes to ...

Builders will break ground Thursday on the latest expansion of an Aliso Viejo corporate campus, to host the new headquarters of the medical instrument firm MicroVention. MicroVention is returning to ...